MED19/LCMR1 Polyclonal Antibody, Cy3 Conjugated
Product Specifications
Background
MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]) .[supplied by OMIM, Oct 2008]
Synonyms
LCMR1; Lung cancer metastasis related protein 1; Lung cancer metastasis-related protein 1; med19; MED19_HUMAN; Mediator complex subunit 19; Mediator of RNA polymerase II transcription subunit 19; Mediator of RNA polymerase II transcription, subunit 19 homolog.
Gene ID
219541
Swiss Prot
A0JLT2
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Rat
Immunogen
51-150/244
Target
MED19
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human MED19/LCMR1
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
219541
Predicted Cross Reactivity
Human, Mouse, Cow, Horse, Chicken
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CGALK-80-50 1 mL
80nm Gold Nanoparticles, Alkyne Terminated, OD 50, Dispersion in H2O
Ask
View Details 
GAT1 1 mL
BV-AGTR1. Recombinant baculovirus expressing angiotensin II receptor (AGTR1).
Ask
View Details